December 12 – Dr. Sherene Loi
Dr. Sherene Loi discusses the development and importance of immune biomarkers in breast cancer, highlighting the TIL biomarker, the limitations of PD-L1, and the potential of new biomarkers to refine treatment algorithms and clinical trials
December 12 – Dr. Sherene Loi Read More »